| Literature DB >> 35530932 |
Mengya Dong1, Chen Li2, Guang Yang1, Qiling Gou1, Qinghua Zhao3, Yuqi Liu3, Xiling Shou1.
Abstract
Background: Coronary pressure-derived fractional flow reverse (FFR) is the standard of the functional assessment of lesion severity. In spite of its strengths in determining ischemia-related coronary stenosis, the invasive operation involved still limits its clinical application. Coronary computed tomography angiography-derived FFR (CCTA-FFR) or computed tomography-derived FFR (CT-FFR) has been indicated as an effective and non-invasive index to evaluate lesion-specific ischemia. However, its diagnostic performance, especially in patients with different severity of coronary stenosis, remains unknown. The current research attempted to demonstrate this problem and provided the foundation for extensive clinical application of CCTA-FFR.Entities:
Keywords: Fractional flow reverse (FFR); Gensini score; coronary artery disease; coronary computed tomography angiography (CCTA)
Year: 2022 PMID: 35530932 PMCID: PMC9073792 DOI: 10.21037/atm-22-881
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Figure 1Cohort selection flow diagram. FFR, fractional flow reverse.
Figure 2Schematic representation of the CT-FFR analysis. CT-FFR, computed tomography-derived fractional flow reverse.
Baseline patient characteristics (n=91)
| Characteristics | Values |
|---|---|
| Male, % | 59 (64.8) |
| Age, years | 62.95±9.35 |
| Body mass index, kg/m2 | 24.75±3.05 |
| Heart rate, bpm | 71 [64, 82] |
| Systolic blood pressure, mmHg | 126 [118, 138] |
| Diastolic blood pressure, mmHg | 78.14±11.05 |
| Past medical history | |
| Diabetes mellitus, % | 22 (24.2) |
| Hypertension, % | 45 (49.5) |
| Hyperlipidemia, % | 22 (24.2) |
| Peripheral vascular disease, % | 8 (8.8) |
| Stroke, % | 8 (8.8) |
| Smoking, % | 19 (20.9) |
| Laboratory test | |
| White blood cell, 109/L | 6.13 [5.43, 7.08] |
| Red blood cell, 1012/L | 4.31 [4.08, 4.85] |
| Platelet, 109/L | 192.85±65.14 |
| Hemoglobin, g/L | 136.05±16.64 |
| Serum creatinine, μmol/L | 73.87±17.99 |
| Blood urea nitrogen, mmol/L | 5.72±1.49 |
| Alanine aminotransferase, U/L | 21 [13, 29] |
| Aspartate aminotransferase, U/L | 22 [18, 27] |
Vessel characteristics (n=97 vessels from 91 patients)
| Characteristics | No. (%) |
|---|---|
| Target vessel | |
| Left anterior descending coronary artery | 65 (67.0) |
| Right coronary artery | 23 (23.7) |
| Left coronary circumflexus artery | 7 (7.2) |
| Left main coronary artery | 2 (2.1) |
| Plaque | |
| Combined plaque | 49 (50.5) |
| Non-calcified plaque | 33 (34.0) |
| Calcified plaque | 15 (15.5) |
| Severity | |
| 30–49% | 29 (29.9) |
| 50–69% | 45 (46.4) |
| 70–90% | 23 (23.7) |
The relationship between CT-FFR and FFR in diagnosis of coronary ischemia
| CT-FFR | FFR | Total | |
|---|---|---|---|
| Positive | Negative | ||
| Positive | 53 | 2 | 55 |
| Negative | 3 | 39 | 42 |
| Total | 56 | 41 | 97 |
CT-FFR, computed tomography-derived fractional flow reverse. FFR, fractional flow reverse.
Figure 3Diagnostic accuracy of resting CT-FFR versus FFR. Black circle means that the test result of CT-FFR is consistent with that of FFR; red circles means that they are inconsistent. CT-FFR, computed tomography-derived fractional flow reverse.
Figure 4Bland-Altman plot of CT-FFR and invasive FFR on a per-vessel basis. CT-FFR, computed tomography-derived fractional flow reverse.
Figure 5Diagnostic accuracy of resting CT-FFR versus FFR and Bland-Altman plot of CT-FFR and invasive FFR on a per-vessel basis in (left-hand) low and (right-hand) high Gensini score subgroups separately. Black circle means that the test result of CT-FFR is consistent with that of FFR; red circles means that they are inconsistent. CT-FFR, computed tomography-derived fractional flow reverse.